Dr Haumschild leads a discussion surrounding the latest advancements in treatment algorithms for myelodysplastic syndrome. The discussion centered on diverse treatment strategies for myelodysplastic ...
New factor XIa inhibitors cut recurrent non-cardioembolic stroke without extra bleeding—plus what milvexian and abilacimab trials reveal. In this installment of this series, ‘The Future of Factor XIa ...
For patients with human papilloma virus (HPV)-associated oropharynx cancer, assessing the presence of cancer cells beyond the lymph nodes, or extranodal extension (ENE), is critical in determining ...
The Pediatric Emergency Medicine and Pediatric Hematology/Oncology divisions at MUSC have joined forces to create and test an algorithm for treating children with sickle cell disease who present to ...
Please provide your email address to receive an email when new articles are posted on . Complex generalists are the best-equipped physicians to perform periprosthetic fracture revisions, according to ...
Costly targeted cancer treatments challenge publicly-funded healthcare systems seeking to align expected benefit with value for money. In 2021, The Canadian Agency for Drugs and Technologies in Health ...
MUSC Children's Health hematologists/oncologists Dr. Michelle Hudspeth (left) and Dr. Shayla Bergmann (right) conducted a study of a new algorithm to standardize the ...
Antimicrobial resistance (AMR) threatens the delivery of effective healthcare 1. The United Nations General Assembly (UNGA) recently committed to prioritizing global use of narrow-spectrum antibiotics ...
Starting today, people with Parkinson’s disease will have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology. The therapy, known as adaptive ...
As part of a focused effort to assess current cardiovascular treatment algorithms for racial bias, the American Heart Association, the single largest non-government supporter of heart and brain ...
The latest type 2 diabetes (T2D) management guidance from the American Association of Clinical Endocrinology (AACE) covers newer diabetes medications, comorbidities, and — for the first time — ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results